Biomarkers and gum health in type 1 diabetes

Summarised from:

Pro-inflammatory biomarkers during experimental gingivitis in patients with type 1 diabetes mellitus: a proof-of-concept study
(Journal of Clinical Periodontology; doi: 10.1111/j.1600-051X.2009.01500.x)

Authors:

Giovanni E. Salvi, Lea M. Franco, Thomas M. Braun, Angie Lee, Gösta Rutger Persson, Niklaus P. Lang, William V. Giannobile

Summarised by:

Dr Dominika Antoniszczak

Research Topic:

Background + Aims

  • Gingivitis (reversible gum disease) is common in people living with diabetes, especially type 1 diabetes (T1DM). This is due to an exaggerated immune response caused by high blood sugar levels, leading to increased inflammation.
  • Gingivitis involves gum inflammation without bone loss, which can be reversed with proper oral hygiene. However, people living with T1DM are more prone to severe gum problems.
  • This study looked at specific proteins called biomarkers found in gum fluid that signal inflammation. The goal was to see if these biomarkers differ between people with and without T1DM during experimental gingivitis.
  • Understanding these differences could improve early detection of gum disease in people with diabetes.

Materials + Methods

  • This study was a secondary analysis of a prospective cohort investigation on experimental gingivitis and T1DM.
  • It included 18 Caucasian participants (9 with T1DM and 9 healthy controls), all age- and gender-matched.
  • Participants with T1DM had a confirmed diagnosis and had been on insulin therapy for ≥ 12 months, with a mean HbA1c level of 8.1%.
  • Healthy subjects had an average HbA1c level of 5.7%.
  • Following prophylaxis and oral hygiene instructions, patients refrained from oral hygiene for 21 days, after which clinical assessments and sample collection were performed.
  • Gingival crevicular fluid (GCF) samples were collected from 4 quadrants of the mouth at baseline, Day 21, and Day 35, totalling 1440 samples.
  • GCF samples were analysed for biomarkers IL-1b, IL-8, MMP-8, and MMP-9 using enzyme-linked immunosorbent assay (ELISA).
  • Subgingival bacterial samples were also collected from four mesiobuccal sites using Gracey curettes, and DNA hybridization techniques were used to quantify bacterial species.
  • Statistical analysis was conducted to compare biomarker levels and bacterial counts.
    • Area under the curve (AUC) analysis was used to summarize biomarker profiles over time.
    • Pearson’s correlation was applied to explore associations between biomarker levels, bacterial species, and clinical measurements

Results

  • Biomarkers:
    • People living with T1DM had significantly higher levels of inflammatory biomarkers (IL-1β, MMP-8, MMP-9) compared to those without diabetes.
    • These markers increased earlier (by Day 7) and stayed higher during the gingivitis period in T1DM patients.
  • Gum health:
    • Both groups showed worsening gum health during the no-brushing phase, but T1DM patients had more severe inflammation.
  • Bacteria:
    • Bacterial composition in the gums was similar in both groups, indicating that the differences in inflammation were due to the body’s immune response, not the bacteria.

Limitations

  • Small sample size (18 participants) limits generalization of results.
  • Study focused on young adults with T1DM, so findings may not apply to other age groups or those with type 2 and other types of diabetes.
  • Biomarker measurement methods may vary between studies, making direct comparisons difficult.

Conclusion

  • People living with T1DM show a stronger and faster inflammatory response to gum bacteria than those without diabetes.
  • Specific biomarkers like IL-1β could help in early detection and monitoring of gum disease in people with diabetes.
  • These findings highlight the importance of close collaboration between dental and medical care for diabetic patients to prevent complications.
Read the full article Back to Research

Research  |  14.12.09

clock icon 5 mins to read

Share this page:

Copy Link

You might also like...

Events

Oral Health Challenges Among People Living With Diabetes

Dr Antoniszczak will present a lecture about the oral health challenges among people living with diabetes. This lecture explores the key challenges faced by individuals living with diabetes, focusing on…

Read more

Events

Periodontitis-Diabetes Hub x #DiabetesChat

Hosted by #diabeteschat, join Dr Varkha Rattu and the team behind the Periodontitis-Diabetes Hub for an insightful discussion exploring the importance of managing periodontitis and diabetes.

Read more

Events

Oral Health Challenges Among People Living With Diabetes

Dr Antoniszczak will present a lecture about the oral health challenges among people living with diabetes. This lecture explores the key challenges faced by individuals living with diabetes, focusing on the relationship between diabetes and oral health.

Read more

Events

Periodontitis-Diabetes Hub x #DiabetesChat

Hosted by #diabeteschat, join Dr Varkha Rattu and the team behind the Periodontitis-Diabetes Hub for an insightful discussion exploring the importance of managing periodontitis and diabetes.

Read more
icon1 services

Periodontitis is the 6th most prevalent condition globally

icon1 services

Periodontitis and diabetes are bidirectionally linked

icon1 services

Diabetic complications are increased if you have both diseases

icon1 services

Successful periodontal treatment can improve blood glucose control

icon1 services

Successful periodontal treatment can improve blood glucose control

icon1 services

Periodontitis is the 6th most prevalent condition globally

icon1 services

Periodontitis and diabetes are bidirectionally linked

icon1 services

Diabetic complications are increased if you have both diseases

icon1 services

Successful periodontal treatment can improve blood glucose control

icon1 services

Successful periodontal treatment can improve blood glucose control

Our Team

Team - The Periodontitis-Diabetes Hub

Dr Varkha Rattu

Founder & Periodontology Co-Lead

Team - The Periodontitis-Diabetes Hub

Dr Amar Puttanna

Diabetes Co-Lead

Team - The Periodontitis-Diabetes Hub

Dr Rajeev Raghavan

Diabetes Co-Lead

Team - The Periodontitis-Diabetes Hub

Professor Mark Ide

Periodontology Co-Lead

Team - The Periodontitis-Diabetes Hub

Professor Luigi Nibali

Periodontology Co-Lead

Team - The Periodontitis-Diabetes Hub

Dr Dominika Antoniszczak

Education & Support Advisor

Team - The Periodontitis-Diabetes Hub

Dr Jasmine Loke

Clinical Content Advisor

Team - The Periodontitis-Diabetes Hub

Dr Mira Shah

Patient Resource Advisor

Team - The Periodontitis-Diabetes Hub

Elaine Tilling

Outreach & Communications Lead

Team - The Periodontitis-Diabetes Hub

Dr Varkha Rattu

Periodontitis-Diabetes Hub Position: Founder & Periodontology Co-Lead

Team - The Periodontitis-Diabetes Hub

Dr Amar Puttanna

Periodontitis-Diabetes Hub Position: Diabetes Co-Lead

Team - The Periodontitis-Diabetes Hub

Dr Rajeev Raghavan

Periodontitis-Diabetes Hub Position: Diabetes Co-Lead

Team - The Periodontitis-Diabetes Hub

Professor Mark Ide

Periodontitis-Diabetes Hub Position: Periodontology Co-Lead

Team - The Periodontitis-Diabetes Hub

Professor Luigi Nibali

Periodontitis-Diabetes Hub Position: Periodontology Co-Lead

Team - The Periodontitis-Diabetes Hub

Dr Dominika Antoniszczak

Periodontitis-Diabetes Hub Position: Education and Support Advisor

Team - The Periodontitis-Diabetes Hub

Dr Jasmine Loke

Periodontitis-Diabetes Hub Position: Clinical Content Advisor

Team - The Periodontitis-Diabetes Hub

Dr Mira Shah

Periodontitis-Diabetes Hub Position: Patient Resource Advisor

Team - The Periodontitis-Diabetes Hub

Elaine Tilling

Periodontitis-Diabetes Hub Position: Outreach and Communications Lead

View All